Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/151844
Title: THE DEVELOPMENT AND APPLICATION OF BIOINFORMATICS TOOLS FOR PRECISE AND QUANTITATIVE THERAPEUTIC INVESTIGATIONS
Authors: ZENG XIAN
ORCID iD:   orcid.org/0000-0002-1397-554X
Keywords: Databases, precision medicine, natural product, drug discovery, ethnicity, genomics
Issue Date: 23-Aug-2018
Citation: ZENG XIAN (2018-08-23). THE DEVELOPMENT AND APPLICATION OF BIOINFORMATICS TOOLS FOR PRECISE AND QUANTITATIVE THERAPEUTIC INVESTIGATIONS. ScholarBank@NUS Repository.
Abstract: This thesis introduced the development and application of two bioinformatics databases for facilitating precision medicine research and natural product (NP)-based drug discovery. I developed the HEROD to provide genomic data of 60283 human samples from diverse ethnic/regional populations, representing a unique resource for ethnic/regional related genomic studies on human diseases including cancers. Based on HEROD, I analysed the difference of gene expression profiles and its clinical relevance between Asian and non-Asian non-small cell lung cancer (NSCLC) patients. The results indicated that Asian and non-Asian NSCLC exhibit different clinically relevant genomic profiles, indicating the molecular clues of ethnic disparities and suggesting that ethnicity should be considered when generalizing genomics-based precision cancer medicine across populations. Moreover, I developed NPASS to provide large-scale quantitative activities of 35032 NPs through extensively mining literature and other resources. NPASS will largely facilitate the NP discovery, optimization of in-silico algorithms for NP-tailored applications, and NP-based drug discovery.
URI: http://scholarbank.nus.edu.sg/handle/10635/151844
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
ZengX.pdf11.82 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.